Sant'Anna School of Advanced Studies, Pisa, Italy.
Global Health & Development, London School of Hygiene & Tropical Medicine (UK), Keppel St, Bloomsbury, London, WC1E 7HT, UK.
Global Health. 2019 Jul 11;15(1):46. doi: 10.1186/s12992-019-0488-4.
Non-communicable diseases in general and cardiovascular diseases in particular are a leading cause of death globally. Trans-fat consumption is a significant risk factor for cardiovascular diseases. The World Health Organization's 'REPLACE' action package of 2018 aims to eliminate it completely in the global food supply by 2023. Legislative and other regulatory actions (i.e., banning trans-fat) are considered as effective means to achieve such a goal. Both wealthier and poorer countries are taking or considering action, as shown by the United States food regulations and Cambodian draft food legislation discussed in this paper. This paper reviews these actions and examines public and private stakeholders' incentives to increase health-protecting or health-promoting standards and regulations at home and abroad, setting the ground for further research on the topic. It focuses on the potential of trade incentives as a potential driver of a 'race to the top'. While it has been documented that powerful countries use international trade instruments to weaken other countries' national regulations, at times these powerful countries may also be interested in more stringent regulations abroad to protect their exports from competition from third countries with less stringent regulations. This article explores practical and principled considerations on how such a dynamic may spread trans-fat restrictions globally. It argues that trade dynamics and public health considerations within powerful countries may help to promote anti-trans-fat regulation globally but will not be sufficient and is ethically questionable. True international regulatory cooperation is needed and could be facilitated by the World Health Organization. Nevertheless, the paper highlights that international trade and investment law offers opportunities for anti-trans-fat policy diffusion globally.
非传染性疾病,尤其是心血管疾病,是全球范围内的主要死亡原因。反式脂肪摄入是心血管疾病的一个重要危险因素。世界卫生组织(WHO)在 2018 年提出了“取代”行动计划,旨在到 2023 年在全球食品供应中彻底消除反式脂肪。立法和其他监管行动(例如,禁止反式脂肪)被认为是实现这一目标的有效手段。无论是富裕国家还是贫穷国家,都在采取或考虑采取行动,美国的食品法规和本文讨论的柬埔寨食品立法草案就是例证。本文回顾了这些行动,并研究了国内外公共和私营利益相关者提高健康保护或促进标准和法规的动机,为进一步研究这一主题奠定了基础。本文重点探讨了贸易激励作为“向高处竞争”的潜在驱动力的可能性。虽然有文件记录表明,强国利用国际贸易工具削弱其他国家的国家法规,但有时这些强国也可能对国外更严格的法规感兴趣,以保护其出口免受来自法规较宽松的第三国的竞争。本文探讨了在全球范围内传播反式脂肪限制的实际和原则性考虑。本文认为,强国内部的贸易动态和公共卫生考虑因素可能有助于促进全球范围内的反反式脂肪监管,但这将是不够的,在伦理上也存在疑问。真正的国际监管合作是必要的,世界卫生组织可以为此提供便利。然而,本文强调,国际贸易和投资法为全球范围内的反式脂肪政策传播提供了机会。